A number of studies have shown that inhibiting SLC7A11, GPX4 or other ferroptosis related molecules can reduce the production of glutathione, thereby promoting tumor cell ferroptosis and suppressing tumor growth and metastasis [30–33]. Here, SLC7A11 is linked to neoplasm.